Patents by Inventor Joseph Hedrick

Joseph Hedrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND DEVICES FOR IDENTIFICATION OF A FEATURE ASSOCIATED WITH A USER IN A GAMING ESTABLISHMENT AND RELATED METHODS
    Publication number: 20220292918
    Abstract: Methods and systems of monitoring at least one feature associated with a patron in a gaming establishment. Such methods and systems may include detecting at least one physical feature associated with the patron and/or motions of one or more players participating in a game.
    Type: Application
    Filed: June 1, 2022
    Publication date: September 15, 2022
    Inventors: Timothy Bucher, Terrin Eager, Bryan M. Kelly, Martin S. Lyons, Joseph Hedrick, Scott Hilbert, Theodore Keenan, John Link, Mohan Kumar Areanalli Manju, Yogendrasinh Hematji Rajput
  • Method for treating pre-type 1 diabetes in a human subject
    Patent number: 11124565
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: September 21, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20190375836
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: August 14, 2019
    Publication date: December 12, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
    Patent number: 10465003
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: November 5, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20190092849
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: February 2, 2017
    Publication date: March 28, 2019
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
    Publication number: 20170247444
    Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).
    Type: Application
    Filed: February 1, 2017
    Publication date: August 31, 2017
    Applicant: Janssen Biotech, Inc.
    Inventors: Joseph Hedrick, Elizabeth C. Hsia, Paul Imm, Jocelyn Leu, Bethany Paxson, Mark Rigby, Songmao Zheng, Ramineh Zoka
  • Method of reducing total cholesterol level by administering matrilin-2 polypeptide
    Patent number: 9089522
    Abstract: The present invention provides, in part, methods and compositions for treating lipid disorders comprising administering a polypeptide that inhibits PCSK9. A novel method for identifying polypeptides that interact with PCSK9 is also provided.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: July 28, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Qing Zhang, Nicholas J. Murgolo, Joseph A. Hedrick
  • ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS
    Publication number: 20140161798
    Abstract: The present invention provides compositions and methods for treating disorders of cholesterol and lipid metabolism by administration of an anti-PCSK9 antibody or a peptide inhibitor of PCSK9.
    Type: Application
    Filed: December 2, 2013
    Publication date: June 12, 2014
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Joseph A. Hedrick, Frederick James Monsma, Tatyana Churakova, Diane Hollenbaugh
  • Anti-PCSK9 and methods for treating lipid and cholesterol disorders
    Patent number: 8598320
    Abstract: The present invention provides compositions and methods for treating disorders of cholesterol and lipid metabolism by administration of an anti-PCSK9 antibody or a peptide inhibitor of PCSK9.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: December 3, 2013
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Joseph A. Hedrick, Frederick James Monsma, Jr., Tatyana Churakova, Diane Hollenbaugh
  • Nucleic acids encoding CCL27
    Patent number: 8119786
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Grant
    Filed: September 14, 2009
    Date of Patent: February 21, 2012
    Assignee: Schering Corporation
    Inventors: Alain Vicari, Janine M. Morales, Joseph Hedrick, Albert Zlotnik
  • EGF-A DOMAIN-MEDIATED MODULATION OF PCKS9 FOR TREATING LIPID DISORDERS
    Publication number: 20110150875
    Abstract: The present invention provides, in part, methods and compositions for treating lipid disorders comprising administering a polypeptide that inhibits PCSK9. A novel method for identifying polypeptides that interact with PCSK9 is also provided.
    Type: Application
    Filed: May 21, 2009
    Publication date: June 23, 2011
    Inventors: Qing Zhang, Nicholas J. Murgolo, Joseph A. Hedrick
  • ANTI-PCSK9 AND METHODS FOR TREATING LIPID AND CHOLESTEROL DISORDERS
    Publication number: 20110033465
    Abstract: The present invention provides compositions and methods for treating disorders of cholesterol and lipid metabolism by administration of an anti-PCSK9 antibody or a peptide inhibitor of PCSK9.
    Type: Application
    Filed: October 27, 2008
    Publication date: February 10, 2011
    Applicant: SCHERING CORPORATION
    Inventors: Joseph A. Hedrick, Frederick James Monsma, JR., Tatyana Churakova, Diane Hollenbaugh
  • MAMMALIAN CHEMOKINES; RELATED REAGENTS
    Publication number: 20100093630
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Application
    Filed: September 14, 2009
    Publication date: April 15, 2010
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph Hedrick, Albert Zlotnik
  • MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
    Publication number: 20100068763
    Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.
    Type: Application
    Filed: November 12, 2009
    Publication date: March 18, 2010
    Inventors: Joseph A. Hedrick, Bernhard Homey, Alain P. Vicari, Monica L. Zepeda, Albert Zlotnik
  • Anti-CCL27 antibodies
    Patent number: 7601815
    Abstract: Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: October 13, 2009
    Assignee: Schering Corporation
    Inventors: Alain P. Vicari, Janine M. Morales, Joseph A. Hedrick, Albert Zlotnik
  • Histamine receptor
    Patent number: 7547523
    Abstract: The present invention provides an isolated mammalian histamine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by histamine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian histamine receptor.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: June 16, 2009
    Assignee: Schering Corporation
    Inventors: Jiang X. Behan, Joseph A. Hedrick, Thomas M. Laz, Frederick James Monsma, Jr., Kelley L. Morse, Shelby P. Umland, Suke Wang
  • Adenosine receptor
    Patent number: 7465789
    Abstract: The present invention provides an isolated mammalian adenosine receptor, isolated or recombinant nucleic acids and recombinant vectors encoding the same, host cells comprising the nucleic acids and vectors, and methods of making the receptor using the host cells. This invention further provides antibodies and antigen binding fragments thereof which specifically bind to the receptor and are useful for treating medical conditions caused or mediated by adenosine. Also provided are screening methods for identifying specific agonists and antagonists of the mammalian adenosine receptor.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: December 16, 2008
    Assignee: Schering Corporation
    Inventors: Joseph A. Hedrick, Jean E. Lachowicz, Wei Wang, Eric L. Gustafson
  • MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
    Publication number: 20080107643
    Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.
    Type: Application
    Filed: October 5, 2007
    Publication date: May 8, 2008
    Inventors: Joseph Hedrick, Bernhard Homey, Alain Vicari, Monica Zepeda, Albert Zlotnik
  • PLAYER TRACKING COMMUNICATION MECHANISMS IN A GAMING MACHINE
    Publication number: 20080051195
    Abstract: A disclosed a player tracking unit provides a multimedia interface with a display and an interface to one or more sound projection devices and a multimedia board for processing digitally formatted program files for output on the multimedia interface. The player tracking unit may provide menus of audio and video programs, such as a menu for a musical jukebox or a menu for a video-on-demand service. Using a “TV-like” interface, a user may be able to select a program to output on the multimedia interface and control playback features of the program.
    Type: Application
    Filed: July 27, 2007
    Publication date: February 28, 2008
    Applicant: IGT
    Inventors: Joseph Hedrick, Binh Nguyen, Mike Kinsley
  • DNAXCCR10
    Patent number: 7307146
    Abstract: Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: December 11, 2007
    Assignees: Schering Corporation, Canji, Inc.
    Inventors: Joseph A. Hedrick, Bernhard Homey, Alain P. Vicari, Monica L. Zepeda, Albert Zlotnik